IDEAS home Printed from https://ideas.repec.org/a/spr/wirtsc/v101y2021i4d10.1007_s10273-021-2894-5.html
   My bibliography  Save this article

Impffortschritt in Deutschland und der Welt: Chancen und Risiken
[Opportunities and Risks of Vaccination Progress]

Author

Listed:
  • Veronika Grimm

    (Friedrich-Alexander-Universität Erlangen-Nürnberg)

  • Franziska K. Lembcke

    (Statistisches Bundesamt)

  • Milena Schwarz

    (Statistisches Bundesamt)

Abstract

Zusammenfassung Deutschland hat sich das Ziel gesetzt, bis zum 21. September 2021 70 % der erwachsenen Bevölkerung ein Impfangebot zu unterbreiten. Der Fortschritt der Impfkampagne hängt dabei wesentlich von drei Determinanten ab: der Impfstoffverfügbarkeit, den Impfkapazitäten sowie der Impfbereitschaft. Auf Basis von Szenarienrechnungen wird aufgezeigt, wie das Ziel der Bundesregierung zu erreichen ist und welche Anforderungen an die Organisation der Impfkampagne dabei gestellt werden müssen. Abschließend werden langfristige Perspektiven und Herausforderungen angesprochen, etwa mit Blick auf die Impfung von Kindern und Jugendlichen oder den weltweiten Impffortschritt.

Suggested Citation

  • Veronika Grimm & Franziska K. Lembcke & Milena Schwarz, 2021. "Impffortschritt in Deutschland und der Welt: Chancen und Risiken [Opportunities and Risks of Vaccination Progress]," Wirtschaftsdienst, Springer;ZBW - Leibniz Information Centre for Economics, vol. 101(4), pages 266-275, April.
    • Handle: RePEc:spr:wirtsc:v:101:y:2021:i:4:d:10.1007_s10273-021-2894-5
    DOI: 10.1007/s10273-021-2894-5
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s10273-021-2894-5
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s10273-021-2894-5?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Cem Çakmaklı & Selva Demiralp & Ṣebnem Kalemli-Özcan & Sevcan Yeşiltaş & Muhammed A. Yıldırım, 2021. "The Economic Case for Global Vaccinations: An Epidemiological Model with International Production Networks," NBER Working Papers 28395, National Bureau of Economic Research, Inc.
    2. Clemens Fuest & Daniel Gros, 2021. "Impfstoffe: Wie man marktbasierte Anreize nutzt, um die Produktion hochzufahren," ifo Schnelldienst Digital, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, vol. 2(03), pages 01-02, January.
    3. Kirchhoff, Jasmina, 2021. "Die Rolle des Staates in der Impfstoffproduktion: Technologische Restriktionen und ökonomische Ableitungen," IW policy papers 3/2021, Institut der deutschen Wirtschaft (IW) / German Economic Institute.
    4. Amrita Ahuja & Susan Athey & Arthur Baker & Eric Budish & Juan Camilo Castillo & Rachel Glennerster & Scott Duke Kominers & Michael Kremer & Jean Lee & Canice Prendergast & Christopher M. Snyder & Ale, 2021. "Preparing for a Pandemic: Accelerating Vaccine Availability," AEA Papers and Proceedings, American Economic Association, vol. 111, pages 331-335, May.
    5. Jan Fries & Niklas Garnadt & Veronika Grimm & Lukas Nöh, 2020. "Europa in der Corona-Krise: Europäische Lieferketten müssen europäisch wiederbelebt werden," Wirtschaftsdienst, Springer;ZBW - Leibniz Information Centre for Economics, vol. 100(6), pages 410-415, June.
    6. Clemens Fuest & Daniel Gros, 2021. "Impfstoffe: Wie man marktbasierte Anreize nutzt, um die Produktion hochzufahren," ifo Schnelldienst Digital, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, vol. 2(3), January.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Dirk Grathwohl(Hrsg.), "undated". "Nachwuchswissenschaftliche Impulse zur empirischen Rechnungslegungsforschung: Band 2 [Young Scientists’ Impetus for Empirical Accounting Research: Volume 2]," Duesseldorf Working Papers in Applied Management and Economics 56, Duesseldorf University of Applied Sciences.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Ockenfels Axel, 2021. "Marktdesign für eine resiliente Impfstoff-produktion," Perspektiven der Wirtschaftspolitik, De Gruyter, vol. 22(3), pages 259-269, September.
    2. Nikhil Agarwal & Andrew Komo & Chetan A. Patel & Parag A. Pathak & M. Utku Ünver, 2021. "The Trade-off Between Prioritization and Vaccination Speed Depends on Mitigation Measures," NBER Working Papers 28519, National Bureau of Economic Research, Inc.
    3. Linus Nyiwul, 2021. "Epidemic Control and Resource Allocation: Approaches and Implications for the Management of COVID-19," Studies in Microeconomics, , vol. 9(2), pages 283-305, December.
    4. D. G. Webster & Semra A. Aytur & Mark Axelrod & Robyn S. Wilson & Joseph A. Hamm & Linda Sayed & Amber L. Pearson & Pedro Henrique C. Torres & Alero Akporiaye & Oran Young, 2022. "Learning from the Past: Pandemics and the Governance Treadmill," Sustainability, MDPI, vol. 14(6), pages 1-26, March.
    5. Chad P. Bown & Thomas J. Bollyky, 2022. "How COVID‐19 vaccine supply chains emerged in the midst of a pandemic," The World Economy, Wiley Blackwell, vol. 45(2), pages 468-522, February.
    6. Çakmaklı, Cem & Demiralp, Selva & Özcan, Şebnem Kalemli & Yeşiltaş, Sevcan & Yıldırım, Muhammed A., 2023. "COVID-19 and emerging markets: A SIR model, demand shocks and capital flows," Journal of International Economics, Elsevier, vol. 145(C).
    7. Bonadio, Barthélémy & Huo, Zhen & Levchenko, Andrei A. & Pandalai-Nayar, Nitya, 2021. "Global supply chains in the pandemic," Journal of International Economics, Elsevier, vol. 133(C).
    8. Jiang, Peng & Klemeš, Jiří Jaromír & Fan, Yee Van & Fu, Xiuju & Tan, Raymond R. & You, Siming & Foley, Aoife M., 2021. "Energy, environmental, economic and social equity (4E) pressures of COVID-19 vaccination mismanagement: A global perspective," Energy, Elsevier, vol. 235(C).
    9. Evenett,Simon J. & Hoekman,Bernard M. & Rocha,Nadia & Ruta,Michele, 2021. "The Covid-19 Vaccine Production Club : Will Value Chains Temper Nationalism?," Policy Research Working Paper Series 9565, The World Bank.
    10. Jean-Charles Bricongne & Juan Carluccio & Lionel Gérard Fontagné & Guillaume Gaulier & Sebastian Stumpner, 2022. "From Macro to Micro: Large Exporters Coping with Common Shocks," CESifo Working Paper Series 9857, CESifo.
    11. Agarwal, Ruchir & Gaule, Patrick, 2022. "What drives innovation? Lessons from COVID-19 R&D," Journal of Health Economics, Elsevier, vol. 82(C).
    12. Aslim, Erkmen Giray & Fu, Wei & Tekin, Erdal & You, Shijun, 2023. "From Syringes to Dishes: Improving Food Security through Vaccination," IZA Discussion Papers 16009, Institute of Labor Economics (IZA).
    13. Yang Ye & Qingpeng Zhang & Xuan Wei & Zhidong Cao & Hsiang-Yu Yuan & Daniel Dajun Zeng, 2022. "Equitable access to COVID-19 vaccines makes a life-saving difference to all countries," Nature Human Behaviour, Nature, vol. 6(2), pages 207-216, February.
    14. L'aszl'o Czaller & GergH{o} T'oth & Bal'azs Lengyel, 2021. "Vaccine allocation to blue-collar workers," Papers 2104.04639, arXiv.org.
    15. Alessandria, George & Khan, Shafaat Yar & Khederlarian, Armen & Mix, Carter & Ruhl, Kim J., 2023. "The aggregate effects of global and local supply chain disruptions: 2020–2022," Journal of International Economics, Elsevier, vol. 146(C).
    16. Ricardo Hausmann & Ulrich Schetter & Muhammed A Yildirim, 2024. "On the design of effective sanctions: the case of bans on exports to Russia," Economic Policy, CEPR, CESifo, Sciences Po;CES;MSH, vol. 39(117), pages 109-153.
    17. Laurence S. J. Roope & Adrian Barnett & Paolo Candio & Mara Violato & Raymond Duch & Philip M. Clarke, 2022. "Is There Broad-Based Support in High-Income Countries for COVID-19 Vaccine Donation? Evidence from Seven Countries," Applied Health Economics and Health Policy, Springer, vol. 20(1), pages 55-65, January.
    18. Snyder, Christopher M. & Hoyt, Kendall & Gouglas, Dimitrios, 2023. "An optimal mechanism to fund the development of vaccines against emerging epidemics," Journal of Health Economics, Elsevier, vol. 91(C).
    19. Clarke, Philip & Loewen, Peter & Bonnefon, Jean-François & Melegaro, Alessia & Friedman, Jorge & Violato, Mara & Barnett, Adrian & Duch, Raymond & Roope, Laurence, 2021. "Public opinion on global rollout of COVID-19 vaccines," TSE Working Papers 21-1214, Toulouse School of Economics (TSE).
    20. Ali K k & Erg n Y kseltan & Mustafa Hekimo lu & Esra Agca Aktunc & Ahmet Y cekaya & Ay e Bilge, 2022. "Forecasting Hourly Electricity Demand Under COVID-19 Restrictions," International Journal of Energy Economics and Policy, Econjournals, vol. 12(1), pages 73-85.

    More about this item

    JEL classification:

    • H4 - Public Economics - - Publicly Provided Goods
    • H12 - Public Economics - - Structure and Scope of Government - - - Crisis Management
    • H51 - Public Economics - - National Government Expenditures and Related Policies - - - Government Expenditures and Health
    • I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:wirtsc:v:101:y:2021:i:4:d:10.1007_s10273-021-2894-5. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.